NSE Approves Shukra Pharmaceuticals Name and Ticker Change to Shukra Medtech
Shukra Pharmaceuticals Ltd 路 Others (Uncategorized) 路 17 Nov 2026, 12:32 am
NSE Approves Shukra Pharmaceuticals Name and Ticker Change to Shukra Medtech NSE has approved the change of name for Shukra Pharmaceuticals Limited to Shukra Medtech Limited, effective 20th Nov'26, following the receipt of a fresh Certificate of Incorporation from the Ministry of Corporate Affairs on 12th Oct'26. Consequently, the company's trading symbol across NSE and BSE will change from SHUKRAPHAR to SHUKRAMED starting 20th Nov'26.
Original exchange filing (PDF)
More announcements from Shukra Pharmaceuticals Ltd
- Media Release 路 05 Nov 2026
- Shukra Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Reg 32 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- SHUKRA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 04 Nov 2026
- The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 路 04 Nov 2026
- SHUKRA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 04 Nov 2026
